Eli Lilly to release data on weight loss drug retatrutide in 2025
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in...
LILLY DRN
F, LLY, HON, ARM and more
Check out the companies making headlines in premarket trading. Ford — The automaker’s shares dropped...
Eli Lilly (LLY) earnings Q4 2024
Eli Lilly on Thursday reported mixed results for the fourth quarter, even as sales of...
CEO Lars Fruergaard Jorgensen discusses Wegovy
It’s been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo’s...
Food as medicine startups could benefit
Robert Kennedy Jr., U.S. President-elect Donald Trump’s nominee to run the Department of Health and...
Novo Nordisk’s Ozempic wins FDA approval for chronic kidney disease
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic to treat chronic kidney...
Trump health care plan likely good for pharmaceutical companies
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady...
Medicare drug price negotiations list includes Ozempic
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,...
Schizophrenia drug Cobenfy could treat Alzheimer’s
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US,...
Stocks making the biggest moves midday: LLY, APLD, BA
Check out the companies making headlines in midday trading. Eli Lilly – The drugmaker’s shares...
